piracetam has been researched along with Acute Onset Vascular Dementia in 8 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 7.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "Patients with cognitive decline from Alzheimer's disease and/or cerebrovascular origin have received the drug, in the first 4 weeks in 4800, later 2400 mg daily doses." | 6.69 | [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. ( Paksy, A; Tariska, P, 2000) |
| "This article investigated the clinical effects of piracetam with nimodipine in the treatment of vascular dementia (VD) after cerebral infarction." | 3.96 | Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction. ( Lei, Z; Wenjing, L; Zhaomin, C; Zongfang, Z, 2020) |
| "Patients with cognitive decline from Alzheimer's disease and/or cerebrovascular origin have received the drug, in the first 4 weeks in 4800, later 2400 mg daily doses." | 2.69 | [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. ( Paksy, A; Tariska, P, 2000) |
| "Vascular dementia is considered a vascular cognitive impairment disease caused by neuronal degeneration in the brain." | 1.51 | Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats. ( Bahnasawy, NH; Elnoby, AS; Fayez, AM; Hassan, O, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, M | 1 |
| Ruan, Z | 1 |
| Chen, B | 1 |
| Wang, Y | 1 |
| Zhou, Z | 1 |
| Ren, S | 1 |
| Wu, L | 1 |
| Tang, N | 1 |
| Zongfang, Z | 1 |
| Wenjing, L | 1 |
| Zhaomin, C | 1 |
| Lei, Z | 1 |
| Furtado, I | 1 |
| Gonçalves, F | 1 |
| Gonçalves, J | 1 |
| Neves, J | 1 |
| Fayez, AM | 1 |
| Elnoby, AS | 1 |
| Bahnasawy, NH | 1 |
| Hassan, O | 1 |
| Zakharov, VV | 1 |
| Gustov, AA | 1 |
| Smirnov, AA | 1 |
| Korshunova, IuA | 1 |
| Andrianova, EV | 1 |
| Stoppe, G | 1 |
| Sandholzer, H | 1 |
| Staedt, J | 1 |
| Winter, S | 1 |
| Kiefer, J | 1 |
| Rüther, E | 1 |
| Tariska, P | 1 |
| Paksy, A | 1 |
1 trial available for piracetam and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
[Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition; Cognition Disorders; Dementia; Dementia, Vasc | 2000 |
7 other studies available for piracetam and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Wuzang Wenyang Huayu decoction regulates differentially expressed transcripts in the rats' hippocampus after cerebral hypoperfusion.
Topics: Animals; Behavior, Animal; Dementia, Vascular; Drugs, Chinese Herbal; Gene Expression Profiling; Gen | 2020 |
Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
Topics: Aged; Calcium Channel Blockers; Case-Control Studies; Cerebral Infarction; Cerebrovascular Circulati | 2020 |
Continuous subcutaneous levetiracetam in end-of-life care.
Topics: Aged, 80 and over; Anticonvulsants; Dementia, Vascular; Disease Progression; Female; Humans; Infusio | 2018 |
Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats.
Topics: Acetylcholine; Animals; Brain; Brain Chemistry; Dementia, Vascular; Drug Therapy, Combination; Indol | 2019 |
[Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia].
Topics: Adult; Aged; Cognition Disorders; Dementia, Vascular; Dizziness; Drug Administration Schedule; Drug | 2010 |
[Phenotropil in the treatment of vascular encephalopathy].
Topics: Dementia, Vascular; Female; Humans; Male; Middle Aged; Nootropic Agents; Piracetam; Psychiatric Stat | 2006 |
Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
Topics: Adult; Alzheimer Disease; Ambulatory Care; Data Collection; Dementia; Dementia, Vascular; Female; Ge | 1996 |